Abstract | INTRODUCTION: The essential issue in conservative treatment is the quality in breast preservation. When risk factors for local relapse exist, a tumour bed boost is required, but the boost choice remains controversial. Prospectively, we studied long-term toxicity, cosmetic outcome and prognostic factors. MATERIALS AND METHODS: After conservative treatment, 115 patients received a single dose of 7 Gy HDR- brachytherapy (HDR-BT) boost between June 1996 and December 2005. Late toxicity was assessed using the LENT- SOMA scale. For esthetic assessment, a subjective scale was used for patients and a modified Fehlauer scale for physicians. Mean age was 56.6 years. Invasive ductal carcinoma (78 %) and lumpectomy (60 %) were predominantly reported. 48 % received chemotherapy (CT). RESULTS: Regarding toxicity, 39 % of patients reported breast pain, 75 % fibrosis, 56 % telangiectasias, 19 % lymphoedema, and 51 % retraction/ atrophy. Concerning management, 22 % of patients with pain and 45 % with lymphoedema were treated. The esthetic result was found satisfactory by 96 % of the patients and 85 % of the physicians. Fibrosis was influenced by CT and a larger irradiated volume and telangiectasias by a greater implant volume. CONCLUSIONS: HDR-BT boost shows good cosmetic effects with acceptable toxicity. Patients overestimate the esthetic outcome. LENT/ SOMA is useful to assess chronic toxicity.
|
Authors | Aurora Rodríguez Pérez, Maria Concepción López Carrizosa, Pilar Maria Samper Ots, José Fermín Pérez-Regadera Gómez, José Zapatero Ortuño, Juan de Dios Sáez Garrido, Manuel Joaquín Martín de Miguel |
Journal | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
(Clin Transl Oncol)
Vol. 14
Issue 12
Pg. 953-60
(Dec 2012)
ISSN: 1699-3055 [Electronic] Italy |
PMID | 22975899
(Publication Type: Journal Article)
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Brachytherapy
(adverse effects)
- Breast
(pathology, radiation effects, surgery)
- Breast Neoplasms
(pathology, radiotherapy, surgery)
- Dose Fractionation, Radiation
- Female
- Humans
- Mastectomy, Segmental
- Middle Aged
- Prospective Studies
- Treatment Outcome
|